Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 271

Similar articles for PubMed (Select 15883980)

1.

Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

Mines D, Hill D, Yu H, Novelli L.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):367-72.

PMID:
15883980
2.

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

Rubino A, Roskell N, Tennis P, Mines D, Weich S, Andrews E.

BMJ. 2007 Feb 3;334(7587):242. Epub 2006 Dec 12.

3.

Suicide risk and choice of antidepressant.

Davis A, Gilhooley M, Agius M, Zaman R.

Psychiatr Danub. 2010 Jun;22(2):358-9.

4.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
5.

Economic appraisal of citalopram in the management of single-episode depression.

Sclar DA, Skaer TL, Robison LM, Galin RS.

J Clin Psychopharmacol. 1999 Oct;19(5 Suppl 1):47S-54S.

PMID:
10507508
6.
7.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

9.
10.

Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.

Lin CH, Lin KS, Lin CY, Chen MC, Lane HY.

J Clin Psychiatry. 2008 Jan;69(1):54-9.

PMID:
18312038
11.

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0. Epub 2009 Jan 22.

PMID:
19165525
12.

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME.

Biol Psychiatry. 2008 Feb 15;63(4):424-34. Epub 2007 Sep 24.

PMID:
17888885
13.

Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.

De Nayer A, Geerts S, Ruelens L, Schittecatte M, De Bleeker E, Van Eeckhoutte I, Evrard JL, Linkowski P, Fossion P, Leyman S, Mignon A.

Int J Neuropsychopharmacol. 2002 Jun;5(2):115-20.

PMID:
12135535
15.

Escitalopram versus venlafaxine XR in the treatment of depression.

Montgomery SA, Andersen HF.

Int Clin Psychopharmacol. 2006 Sep;21(5):297-309.

PMID:
16877901
16.

Causal or casual?

Egberts TC.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):365-6. No abstract available.

PMID:
15924331
17.

Antidepressants and the risk of suicidal behaviors.

Jick H, Kaye JA, Jick SS.

JAMA. 2004 Jul 21;292(3):338-43.

PMID:
15265848
18.
19.

Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine.

Yu-Isenberg KS, Fontes CL, Wan GJ, Geissler EC, Harada AS.

Pharmacotherapy. 2004 Jan;24(1):33-40.

PMID:
14740786
20.

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.

Int Clin Psychopharmacol. 2005 Jul;20(4):233-8.

PMID:
15933485
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk